FDA rejects Singulair-Claritin combination

Apr 30, 2008

The U.S. Food and Drug Administration rejected a proposed pill that would combine the drugs Claritin and Singular, Schering-Plough said.

The drug, a combination of loratadine and montelukast developed in a joint venture between Schering-Plough and Merck Pharmaceuticals, was targeted for patients with allergic rhinitis symptoms and nasal congestion.

The active ingredients of Claritin is loratadine and the active ingredient of Singulair is montelukast sodium. Both drugs are indicated for the relief of symptoms of seasonal allergic rhinitis and perennial allergic rhinitis, the two drug companies said in a statement.

The companies did not explain the FDA's reason for rejecting the drug combo.

Copyright 2008 by United Press International

Explore further: Methadone linked to initial QTc prolongation in chronic pain

Related Stories

Monster black hole wakes up after 26 years

1 hour ago

Over the past week, ESA's Integral satellite has been observing an exceptional outburst of high-energy light produced by a black hole that is devouring material from its stellar companion.

HBO launches two new shows on Facebook

2 hours ago

HBO posted the first episodes of its two newest comedy series on Facebook on Thursday, turning the social networking site into a new platform for TV viewing.

A look at challenges Uber has faced around the world

2 hours ago

Taxi drivers in France went on strike Thursday, smashing car windows, setting tires on fire and blocking traffic to express their displeasure with American ride-hailing service Uber. Despite an October law ...

Recommended for you

FDA reviewing safety of Essure birth control implant

Jun 25, 2015

Federal health regulators are reviewing the safety of an implantable contraception device after receiving reports of unusual side effects from patients, including fatigue, depression and weight gain.

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.